The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Antiandrogen Market Research Report 2025

Global Antiandrogen Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1733333

No of Pages : 93

Ask Your Query

Synopsis

Highlights
The global Antiandrogen market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Antiandrogen is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Antiandrogen is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Antiandrogen in Prostate Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Antiandrogen include Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui and Bayer, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Antiandrogen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiandrogen.
The Antiandrogen market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antiandrogen market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiandrogen companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

  • Pfizer
  • Johnson & Johnson
  • Astrazeneca
  • Astellas
  • Merck
  • Sanofi
  • Orion Corporation
  • Hengrui
  • Bayer
  • Schering-Plough
  • Hinova Pharma
  • Jiangsu Hengrui Pharmaceuticals

Segment by Type

  • Steroidal Antiandrogen
  • Nonsteroidal Antiandrogen

Segment by Application

  • Prostate Cancer
  • Benign Prostatic Hyperplasia
  • Polycystic Ovary Syndrome (POCS)
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiandrogen companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiandrogen Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Steroidal Antiandrogen
1.2.3 Nonsteroidal Antiandrogen
1.3 Market by Application
1.3.1 Global Antiandrogen Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Prostate Cancer
1.3.3 Benign Prostatic Hyperplasia
1.3.4 Polycystic Ovary Syndrome (POCS)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiandrogen Market Perspective (2018-2029)
2.2 Antiandrogen Growth Trends by Region
2.2.1 Global Antiandrogen Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antiandrogen Historic Market Size by Region (2018-2023)
2.2.3 Antiandrogen Forecasted Market Size by Region (2024-2029)
2.3 Antiandrogen Market Dynamics
2.3.1 Antiandrogen Industry Trends
2.3.2 Antiandrogen Market Drivers
2.3.3 Antiandrogen Market Challenges
2.3.4 Antiandrogen Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiandrogen Players by Revenue
3.1.1 Global Top Antiandrogen Players by Revenue (2018-2023)
3.1.2 Global Antiandrogen Revenue Market Share by Players (2018-2023)
3.2 Global Antiandrogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiandrogen Revenue
3.4 Global Antiandrogen Market Concentration Ratio
3.4.1 Global Antiandrogen Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiandrogen Revenue in 2022
3.5 Antiandrogen Key Players Head office and Area Served
3.6 Key Players Antiandrogen Product Solution and Service
3.7 Date of Enter into Antiandrogen Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiandrogen Breakdown Data by Type
4.1 Global Antiandrogen Historic Market Size by Type (2018-2023)
4.2 Global Antiandrogen Forecasted Market Size by Type (2024-2029)
5 Antiandrogen Breakdown Data by Application
5.1 Global Antiandrogen Historic Market Size by Application (2018-2023)
5.2 Global Antiandrogen Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Antiandrogen Market Size (2018-2029)
6.2 North America Antiandrogen Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antiandrogen Market Size by Country (2018-2023)
6.4 North America Antiandrogen Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiandrogen Market Size (2018-2029)
7.2 Europe Antiandrogen Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antiandrogen Market Size by Country (2018-2023)
7.4 Europe Antiandrogen Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiandrogen Market Size (2018-2029)
8.2 Asia-Pacific Antiandrogen Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antiandrogen Market Size by Region (2018-2023)
8.4 Asia-Pacific Antiandrogen Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiandrogen Market Size (2018-2029)
9.2 Latin America Antiandrogen Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antiandrogen Market Size by Country (2018-2023)
9.4 Latin America Antiandrogen Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiandrogen Market Size (2018-2029)
10.2 Middle East & Africa Antiandrogen Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antiandrogen Market Size by Country (2018-2023)
10.4 Middle East & Africa Antiandrogen Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Antiandrogen Introduction
11.1.4 Pfizer Revenue in Antiandrogen Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Antiandrogen Introduction
11.2.4 Johnson & Johnson Revenue in Antiandrogen Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Antiandrogen Introduction
11.3.4 AstraZeneca Revenue in Antiandrogen Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Astellas
11.4.1 Astellas Company Detail
11.4.2 Astellas Business Overview
11.4.3 Astellas Antiandrogen Introduction
11.4.4 Astellas Revenue in Antiandrogen Business (2018-2023)
11.4.5 Astellas Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Antiandrogen Introduction
11.5.4 Merck Revenue in Antiandrogen Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Antiandrogen Introduction
11.6.4 Sanofi Revenue in Antiandrogen Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Orion Corporation
11.7.1 Orion Corporation Company Detail
11.7.2 Orion Corporation Business Overview
11.7.3 Orion Corporation Antiandrogen Introduction
11.7.4 Orion Corporation Revenue in Antiandrogen Business (2018-2023)
11.7.5 Orion Corporation Recent Development
11.8 Hengrui
11.8.1 Hengrui Company Detail
11.8.2 Hengrui Business Overview
11.8.3 Hengrui Antiandrogen Introduction
11.8.4 Hengrui Revenue in Antiandrogen Business (2018-2023)
11.8.5 Hengrui Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Antiandrogen Introduction
11.9.4 Bayer Revenue in Antiandrogen Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 Schering-Plough
11.10.1 Schering-Plough Company Detail
11.10.2 Schering-Plough Business Overview
11.10.3 Schering-Plough Antiandrogen Introduction
11.10.4 Schering-Plough Revenue in Antiandrogen Business (2018-2023)
11.10.5 Schering-Plough Recent Development
11.11 Hinova Pharma
11.11.1 Hinova Pharma Company Detail
11.11.2 Hinova Pharma Business Overview
11.11.3 Hinova Pharma Antiandrogen Introduction
11.11.4 Hinova Pharma Revenue in Antiandrogen Business (2018-2023)
11.11.5 Hinova Pharma Recent Development
11.12 Jiangsu Hengrui Pharmaceuticals
11.12.1 Jiangsu Hengrui Pharmaceuticals Company Detail
11.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.12.3 Jiangsu Hengrui Pharmaceuticals Antiandrogen Introduction
11.12.4 Jiangsu Hengrui Pharmaceuticals Revenue in Antiandrogen Business (2018-2023)
11.12.5 Jiangsu Hengrui Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Antiandrogen Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Steroidal Antiandrogen
Table 3. Key Players of Nonsteroidal Antiandrogen
Table 4. Global Antiandrogen Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Antiandrogen Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Antiandrogen Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Antiandrogen Market Share by Region (2018-2023)
Table 8. Global Antiandrogen Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Antiandrogen Market Share by Region (2024-2029)
Table 10. Antiandrogen Market Trends
Table 11. Antiandrogen Market Drivers
Table 12. Antiandrogen Market Challenges
Table 13. Antiandrogen Market Restraints
Table 14. Global Antiandrogen Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Antiandrogen Market Share by Players (2018-2023)
Table 16. Global Top Antiandrogen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiandrogen as of 2022)
Table 17. Ranking of Global Top Antiandrogen Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Antiandrogen Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antiandrogen Product Solution and Service
Table 21. Date of Enter into Antiandrogen Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antiandrogen Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Antiandrogen Revenue Market Share by Type (2018-2023)
Table 25. Global Antiandrogen Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Antiandrogen Revenue Market Share by Type (2024-2029)
Table 27. Global Antiandrogen Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Antiandrogen Revenue Market Share by Application (2018-2023)
Table 29. Global Antiandrogen Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Antiandrogen Revenue Market Share by Application (2024-2029)
Table 31. North America Antiandrogen Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Antiandrogen Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Antiandrogen Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Antiandrogen Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Antiandrogen Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Antiandrogen Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Antiandrogen Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Antiandrogen Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Antiandrogen Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Antiandrogen Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Antiandrogen Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Antiandrogen Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Antiandrogen Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Antiandrogen Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Antiandrogen Market Size by Country (2024-2029) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Antiandrogen Product
Table 49. Pfizer Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Antiandrogen Product
Table 54. Johnson & Johnson Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. AstraZeneca Company Detail
Table 57. AstraZeneca Business Overview
Table 58. AstraZeneca Antiandrogen Product
Table 59. AstraZeneca Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 60. AstraZeneca Recent Development
Table 61. Astellas Company Detail
Table 62. Astellas Business Overview
Table 63. Astellas Antiandrogen Product
Table 64. Astellas Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 65. Astellas Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck Antiandrogen Product
Table 69. Merck Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Sanofi Company Detail
Table 72. Sanofi Business Overview
Table 73. Sanofi Antiandrogen Product
Table 74. Sanofi Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Orion Corporation Company Detail
Table 77. Orion Corporation Business Overview
Table 78. Orion Corporation Antiandrogen Product
Table 79. Orion Corporation Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 80. Orion Corporation Recent Development
Table 81. Hengrui Company Detail
Table 82. Hengrui Business Overview
Table 83. Hengrui Antiandrogen Product
Table 84. Hengrui Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 85. Hengrui Recent Development
Table 86. Bayer Company Detail
Table 87. Bayer Business Overview
Table 88. Bayer Antiandrogen Product
Table 89. Bayer Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Schering-Plough Company Detail
Table 92. Schering-Plough Business Overview
Table 93. Schering-Plough Antiandrogen Product
Table 94. Schering-Plough Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 95. Schering-Plough Recent Development
Table 96. Hinova Pharma Company Detail
Table 97. Hinova Pharma Business Overview
Table 98. Hinova Pharma Antiandrogen Product
Table 99. Hinova Pharma Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 100. Hinova Pharma Recent Development
Table 101. Jiangsu Hengrui Pharmaceuticals Company Detail
Table 102. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 103. Jiangsu Hengrui Pharmaceuticals Antiandrogen Product
Table 104. Jiangsu Hengrui Pharmaceuticals Revenue in Antiandrogen Business (2018-2023) & (US$ Million)
Table 105. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiandrogen Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Antiandrogen Market Share by Type: 2022 VS 2029
Figure 3. Steroidal Antiandrogen Features
Figure 4. Nonsteroidal Antiandrogen Features
Figure 5. Global Antiandrogen Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Antiandrogen Market Share by Application: 2022 VS 2029
Figure 7. Prostate Cancer Case Studies
Figure 8. Benign Prostatic Hyperplasia Case Studies
Figure 9. Polycystic Ovary Syndrome (POCS) Case Studies
Figure 10. Others Case Studies
Figure 11. Antiandrogen Report Years Considered
Figure 12. Global Antiandrogen Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Antiandrogen Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Antiandrogen Market Share by Region: 2022 VS 2029
Figure 15. Global Antiandrogen Market Share by Players in 2022
Figure 16. Global Top Antiandrogen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiandrogen as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Antiandrogen Revenue in 2022
Figure 18. North America Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Antiandrogen Market Share by Country (2018-2029)
Figure 20. United States Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Antiandrogen Market Share by Country (2018-2029)
Figure 24. Germany Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Antiandrogen Market Share by Region (2018-2029)
Figure 32. China Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Antiandrogen Market Share by Country (2018-2029)
Figure 40. Mexico Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Antiandrogen Market Share by Country (2018-2029)
Figure 44. Turkey Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Antiandrogen Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 47. Johnson & Johnson Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 49. Astellas Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 52. Orion Corporation Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 53. Hengrui Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 54. Bayer Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 55. Schering-Plough Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 56. Hinova Pharma Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 57. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Antiandrogen Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock